<rss version="2.0">
  <channel>
    <title>2024年第3期</title>
    <link>https://jhip.gdpu.edu.cn/2024%E5%B9%B4%E7%AC%AC3%E6%9C%9F</link>
    <description><![CDATA[]]></description>
    <item>
      <title>Cover page</title>
      <link>https://jhip.gdpu.edu.cn/47qwcfsn6g12x34fgb2hvv7pny</link>
      <description><![CDATA[]]></description>
      <pubDate>Thu, 10 Oct 2024 08:29:21 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/47qwcfsn6g12x34fgb2hvv7pny</guid>
    </item>
    <item>
      <title>Table of Contents</title>
      <link>https://jhip.gdpu.edu.cn/4xfe0raxaz2x60q93sjdrw8t4f</link>
      <description><![CDATA[]]></description>
      <pubDate>Thu, 10 Oct 2024 08:28:28 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4xfe0raxaz2x60q93sjdrw8t4f</guid>
    </item>
    <item>
      <title>Holistic integrative medicine declaration</title>
      <link>https://jhip.gdpu.edu.cn/4zdyvp45n4ksny2xghp7xm6d4t</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">Holistic integrative medicine declaration</span><span style="font-size:
14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:0pt">（整合医学宣言英文版）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
mso-font-kerning:0pt">&nbsp; </span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">整体整合医学简称整合医学，自<span lang="EN-US">2012</span>年正式提出以来，其理论体系不断完善，实践方法日趋丰富，成为医学发展新时代的必然选择和必由之路。本文提出整合医学的十大主张，从认识论和方法学上阐述了整合医学的内涵和外延，以期实现现代医学的升维转型和自适应进化。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">关键词<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
mso-font-kerning:0pt">&nbsp; </span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">整体整合医学；整合医学；医学发展<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:26:15 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4zdyvp45n4ksny2xghp7xm6d4t</guid>
    </item>
    <item>
      <title>Preparation of purine functionalized biochar and analysis of nephrotoxic substances in traditional Chinese medicine</title>
      <link>https://jhip.gdpu.edu.cn/4p1ykrtfwqx7y3x9x24m00cdw9</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">Preparation of purine functionalized biochar and analysis of nephrotoxic
substances in traditional Chinese medicine </span><span style="font-size:14.0pt;
font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:0pt">（嘌呤功能化生物炭的制备及中药肾毒性物质分析）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">近年来，由于对中药的安全性缺乏了解，导致药物引起的器官损伤，特别是与中药使用相关的肾脏损伤的发生率不断上升。本研究的重点是制备嘌呤功能化生物炭，用于捕获中药中的肾毒性物质。利用扫描电子显微镜（<span lang="EN-US">SEM</span>）、傅立叶变换红外光谱（<span lang="EN-US">FT-IR</span>）、<span lang="EN-US">X</span>射线光电子能谱（<span lang="EN-US">XPS</span>）和元素分析对嘌呤功能化生物炭进行了表征。随后，将其用作固相萃取介质，用于捕获中药中疑似肾毒性物质。结果显示，嘌呤功能化生物炭对具有肾毒性作用的化合物表现出一定的选择性，证明了其有效捕获中药中肾毒性物质的潜力。本研究旨在引入一种新方法来大规模检测中药中潜在的肾毒性物质，从而有助于提高中药的整体安全性。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">关键词<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">生物炭；嘌呤功能化材料；肾毒性物质；中医药<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:25:30 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4p1ykrtfwqx7y3x9x24m00cdw9</guid>
    </item>
    <item>
      <title>Puerarin alleviates LPS-induced endothelial cells injury via SIRT1-mediated mitochondrial homeostasis signaling</title>
      <link>https://jhip.gdpu.edu.cn/4s11f9wc3bvd44anbvr696f05p</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">Puerarin alleviates LPS-induced endothelial cells injury via
SIRT1-mediated mitochondrial homeostasis signaling</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">（葛根素通过<span lang="EN-US">SIRT1</span>介导的线粒体稳态减轻<span lang="EN-US">LPS</span>诱导的内皮细胞损伤）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">内皮炎症损伤是各种心血管疾病病理过程中发生的关键机制。葛根素（<span lang="EN-US">PUE</span>）是一种异黄酮化合物，具有很强的抗氧化性能，是从葛根根茎中分离出来的主要活性成分。<span lang="EN-US">PUE</span>具有良好的抗动脉粥样硬化药理作用，但对其对内皮细胞保护作用的机制研究较少。本研究发现，<span lang="EN-US">PUE</span>可以在一定程度上调节人脐静脉内皮细胞（<span lang="EN-US">HUVECs</span>）的线粒体功能，减少或抑制脂多糖诱导的<span lang="EN-US">HUVECs</span>炎症反应和氧化应激损伤。此外，<span lang="EN-US">PUE</span>对<span lang="EN-US">HUVECs</span>的保护作用与<span lang="EN-US">SIRT-1</span>信号通路密切相关。<span lang="EN-US">PUE</span>通过增加<span lang="EN-US">SIRT-1</span>的表达、减少<span lang="EN-US">ROS</span>的过量产生、抑制炎症因子的表达和氧化应激损伤，提高了线粒体自噬水平和线粒体抗氧化酶的活性。因此，<span lang="EN-US">PUE</span>可能改善线粒体呼吸功能和能量代谢，增加<span lang="EN-US">HUVEC</span>在炎症状态下的活性。<span lang="EN-US"><o:p></o:p></span></span></p><p>



<b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-ansi-language:EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">[</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">关键词<span lang="EN-US">]&nbsp; </span></span></b><span style="font-size:
14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-ansi-language:EN-US;
mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">葛根素；内皮炎症损伤；血管；<span lang="EN-US">SIRT-1</span>；线粒体</span><br></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:22:06 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4s11f9wc3bvd44anbvr696f05p</guid>
    </item>
    <item>
      <title>Safety and risk control study of antibody preparation based on CiteSpace</title>
      <link>https://jhip.gdpu.edu.cn/4x3cqf6hckha1vn9hb22xgkkm4</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">Safety and risk control study of antibody preparation based on CiteSpace</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">（基于<span lang="EN-US">CiteSpace</span>的抗体制备安全与风险控制研究）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">] </span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
mso-font-kerning:0pt">&nbsp;</span><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">目的</span></b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt"> 分析近<span lang="EN-US">20</span>年来抗体制剂安全性研究的热点、规律和分布情况，并对抗体制剂安全性和风险控制研究的现状和趋势进行总结。<b>方法</b>
以“抗体制备”、“安全性”和“风险”等为关键词，在<span lang="EN-US">Web of Science</span>数据库中检索相关文献，利用<span lang="EN-US">CiteSpace</span>分析每年的论文出版数量、国家、作者、机构、高被引文献，筛选文献的关键词，以及绘制相关图谱并对结果进行分析。<b>结果</b>
共纳入<span lang="EN-US">1693</span>篇文献。<span lang="EN-US">2002</span>―<span lang="EN-US">2022</span>年，抗体制备安全性领域的年度出版物数量先呈稳定增长趋势，随后快速增长。在这些国家中，美国占出版物总数的<span lang="EN-US">36.7%</span>，位居世界第一。大型外国制药公司、研究机构、综合性大学及其附属医院为主要的发文机构。目前抗体制剂安全性研究领域的热点包括“抗体药物符合物（<a name="_Hlk176265781"><span lang="EN-US">antibody drug conjugate</span></a>）”、“单克隆抗体”、“抗肿瘤活性”、“免疫疗法”等。<b>结论</b>
近<span lang="EN-US">20</span>年来，国内外对抗体制剂的关注度越来越高，研究主要集中在疗效和安全性方面，风险控制的研究比较少，未来还需对<a name="_Hlk176265581">抗体制剂</a>不良反应的发生机制进行更深入的研究，为抗体制剂的风险控制提供更为有效的策略。<span lang="EN-US"><o:p></o:p></span></span></p><p>



<b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-ansi-language:EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">[</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">关键词<span lang="EN-US">]</span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
mso-ansi-language:EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">&nbsp; </span><span style="font-size:14.0pt;
font-family:华文中宋;mso-bidi-font-family:仿宋;mso-ansi-language:EN-US;mso-fareast-language:
ZH-CN;mso-bidi-language:AR-SA">抗体制剂；<span lang="EN-US">CiteSpace</span>；抗体药物符合物；单克隆抗体；研究热点；安全性</span><br></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:20:53 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4x3cqf6hckha1vn9hb22xgkkm4</guid>
    </item>
    <item>
      <title>Zebrafish as A Rapid Model System for Early Cardiotoxicity Assessment of Drugs</title>
      <link>https://jhip.gdpu.edu.cn/4g9ev44f63kt3y4k3dzhfhfpw1</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">Zebrafish as A Rapid Model System for Early Cardiotoxicity Assessment of
Drugs</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">（斑马鱼模型系统在快速评估药物早期心脏毒性中的比较研究）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">]&nbsp;
</span>目的</span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt"> 药物的斑马鱼心脏毒性评价存在指标不系统、敏感性弱等问题，探讨各种评价方法在快速心脏毒性评估中的优缺点，识别并确立具有代表性和高敏感性的评价指标。<b>方法</b>
采用斑马鱼模型，选取<span lang="EN-US">4</span>种不同浓度典型心脏毒性药物<span lang="EN-US">(</span>阿霉素、<span lang="EN-US">5-</span>氟尿嘧啶、布洛芬和利多卡因<span lang="EN-US">)</span>作用于斑马鱼胚胎，通过体视显微镜观察并记录各组斑马鱼的死亡、心脏畸形、心率、血流量和<span lang="EN-US">SV-BA</span>距离。使用斑马鱼行为记录仪，统计并分析斑马鱼在药物处理后的行为学变化。利用成年斑马鱼筛选心脏毒性表达基因，对特异性高表达的基因进行时空表达稳定性和浓度<span lang="EN-US">-</span>剂量依赖性研究。<b>结果</b> 四种药物均能不同程度的降低斑马鱼胚胎心率和血流速度、增大斑马鱼胚胎<span lang="EN-US">SV-BA</span>距离和降低斑马鱼的活动行为，对斑马鱼心脏功能具有不同程度的抑制作用。选取的<span lang="EN-US">12</span>个只在心脏表达的基因，有且仅有<span lang="EN-US">CMLC1</span>在斑马鱼心脏中存在较高的特异性表达。但药物浓度<span lang="EN-US">-</span>剂量依赖性实验表明阿霉素不影响<span lang="EN-US">CMLC1</span>基因表达，其余<span lang="EN-US">3</span>种药物均能显著诱导该基因上调表达。<b>结论</b>
与传统的心脏毒性评价指标（心率、血流速度和<span lang="EN-US">SV-BA</span>距离）相比，行为学是一种更快、更灵敏的方法。斑马鱼具有较少的高心脏特异性表达基因，不适合仅基于循环<span lang="EN-US">mRNA</span>的心脏特异性表达来评估心脏毒性。<span lang="EN-US"><o:p></o:p></span></span></p><p>



<b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-ansi-language:EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">[</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">关键词<span lang="EN-US">]&nbsp; </span></span></b><span style="font-size:
14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-ansi-language:EN-US;
mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">行为；药物引起的心脏毒性；快速检测；斑马鱼</span><br></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:19:24 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4g9ev44f63kt3y4k3dzhfhfpw1</guid>
    </item>
    <item>
      <title>Supplementary data: Zebrafish as A Rapid Model System for Early Cardiotoxicity Assessment of Drugs</title>
      <link>https://jhip.gdpu.edu.cn/4n87kf1r60ekdxpd8wjwwnj1dk</link>
      <description><![CDATA[]]></description>
      <pubDate>Thu, 10 Oct 2024 08:18:37 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4n87kf1r60ekdxpd8wjwwnj1dk</guid>
    </item>
    <item>
      <title>Supplementary data: Zebrafish as A Rapid Model System for Early Cardiotoxicity Assessment of Drugs</title>
      <link>https://jhip.gdpu.edu.cn/438f3gqghcjy22jm4bcsp97kxq</link>
      <description><![CDATA[]]></description>
      <pubDate>Thu, 10 Oct 2024 08:17:46 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/438f3gqghcjy22jm4bcsp97kxq</guid>
    </item>
    <item>
      <title>Potential anti-colon cancer agents: Molecular modelling, docking, pharmacokinetics studies and molecular dynamic simulations</title>
      <link>https://jhip.gdpu.edu.cn/4xc9j3k02z2xm4q5c7b60s2pxh</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">Potential anti-colon cancer agents: Molecular modelling, docking,
pharmacokinetics studies and molecular dynamic simulations</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">（潜在的抗克隆癌症药物：分子模型、对接、药代动力学研究和分子动力学模拟）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">]&nbsp;
</span>目的 </span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">使用从文献中获得的实验数据，创建一个可信赖的<span lang="EN-US">QSAR</span>模型，将该模型应用于结肠癌癌症的治疗成本低，且几乎无副作用。<b>方法</b> 用<span lang="EN-US">ChemDraw</span>软件创建分子结构，<span lang="EN-US">Spartan 14</span>软件对其进行优化并生成量子化学描述符，用特定的软件包进行数据预处理和数据划分。此外，用一些软件工具进行分析和验证，如用<span lang="EN-US">Discovery Studio Visualizer</span>和<span lang="EN-US">PyRx</span>进行分子对接，<span lang="EN-US">SwissADM</span>用于药代动力学研究，<span lang="EN-US">Desmond</span>用于分子动力学模拟等。<b>结果</b>
开发的<span lang="EN-US">QSAR</span>模型预测质量良好，平均绝对误差（<span lang="EN-US">MAE</span>）为<span lang="EN-US">1.3313</span>，内部验证指标较高（<span lang="EN-US">R<sup>2</sup>=0.9407</span>，调整后的<span lang="EN-US">R<sup>2</sup>=0.9329</span>）。对测试集的外部验证结果良好（<span lang="EN-US">R<sup>2</sup>=0.9012</span>，调整后的<span lang="EN-US">R<sup>2</sup>=0.8436</span>，<span lang="EN-US">CCC=0.9229</span>）。对接分析确定化合物<span lang="EN-US">112</span>和<span lang="EN-US">111</span>具有<span lang="EN-US">-10.4
kj/mol</span>的最低结合亲和力，表明其特定的分子性质。此外，分子动力学（<span lang="EN-US">Molecular Dynamic</span>，<span lang="EN-US">MD</span>）模拟提供了对蛋白质<span lang="EN-US">-</span>配体复合物的动态行为和相互作用类型的认知，有助于更深入地了解它们的稳定性。<b>结论</b>
模型验证参数证实了模型的可靠性和耐用性。药代动力学研究通过各种参数验证了候选药物的成药性。<span lang="EN-US">MD</span>模拟揭示了蛋白质<span lang="EN-US">-</span>配体复合物的动态行为和相互作用类型，有助于我们对其稳定性和波动的认识。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">关键词<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">结直肠；对接；<span lang="EN-US">Quantitative
Structure-Activity Relationship</span>；动态模拟；<span lang="EN-US">ADMET</span>；癌症<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:15:19 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4xc9j3k02z2xm4q5c7b60s2pxh</guid>
    </item>
    <item>
      <title>Supplementary data: Potential anti-colon cancer agents: Molecular modelling, docking, pharmacokinetics studies and molecular dynamic simulations</title>
      <link>https://jhip.gdpu.edu.cn/4vvct36w0w6dt5vmvnnh6fb24s</link>
      <description><![CDATA[]]></description>
      <pubDate>Thu, 10 Oct 2024 08:14:28 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4vvct36w0w6dt5vmvnnh6fb24s</guid>
    </item>
    <item>
      <title>Ferroptosis: a prospective therapeutic target for radiotherapy- and chemotherapy-induced gastrointestinal inflammation</title>
      <link>https://jhip.gdpu.edu.cn/4657en9vrsaq746sz0vaffc6xh</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">Ferroptosis: a prospective therapeutic target for radiotherapy- and
chemotherapy-induced gastrointestinal inflammation</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">（铁死亡：放疗和化疗所致胃肠道炎症的潜在治疗靶点）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">铁死亡是由铁依赖性脂质过氧化驱动的一种独特的细胞死亡模式，该过程受多种细胞代谢途径的调控，包括氧化还原平衡、铁稳态和脂质代谢等。研究表明，放疗和化疗引起的胃肠道炎症表现出铁死亡的主要特征，包括铁沉积、谷胱甘肽（<span lang="EN-US">GSH</span>）耗竭、谷胱甘肽过氧化物酶<span lang="EN-US">4</span>（<span lang="EN-US">GPX4</span>）失活和脂质过氧化。通过文献梳理我们发现，铁死亡在放疗和化疗诱发的胃肠炎症的病理机制中具有重要作用，通过提高<span lang="EN-US">GSH</span>水平、激活<span lang="EN-US">GPX4</span>、抑制脂质过氧化水平的升高以及维持铁稳态能够显著缓解放疗和化疗诱发的胃肠炎症。由此提示靶向铁死亡相关信号通路可能是治疗放化疗所致胃肠炎症的新靶点。此外，本文还系统总结了传统中药及其所含有效成分在治疗放化疗所致胃肠炎症中的作用机制。中药通过作用于铁死亡关键信号通路和相关介质，如<span lang="EN-US">Nrf2/HO-1</span>、<span lang="EN-US">GSH/GPX4</span>、多不饱和脂肪酸（<span lang="EN-US">PUFAs</span>）、铁离子浓度和有机过氧化物等，从而抑制铁死亡，进而有效改善放化疗引起的胃肠道炎症。本综述为放化疗所致的胃肠炎症提出了一种新的潜在治疗策略，同时表明了中医药在现代医学治疗中的潜在价值。<span lang="EN-US"><o:p></o:p></span></span></p><p>



<b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-ansi-language:EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">[</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">关键词<span lang="EN-US">]&nbsp; </span></span></b><span style="font-size:
14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-ansi-language:EN-US;
mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA">铁死亡；放疗；化疗；胃肠道炎症；中医药</span><br></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:08:10 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4657en9vrsaq746sz0vaffc6xh</guid>
    </item>
    <item>
      <title>Research progress in application of alginate gel as tumor drug delivery carrier, for tumor localization and 3D tumor cell model</title>
      <link>https://jhip.gdpu.edu.cn/4xhr10tdjhfk357bbvn8bha5xv</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">Research progress in application of alginate gel as tumor drug delivery
carrier, for tumor localization and 3D tumor cell model</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">（海藻酸凝胶作为肿瘤药物递送载体、用于肿瘤定位及<span lang="EN-US">3D</span>肿瘤细胞模型的应用研究进展）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">作为生物医学研究的热点材料之一，海藻酸盐凝胶以其独特的物理和化学性质在肿瘤治疗中显示出巨大的潜力。为了更好地满足肿瘤治疗的复杂需求，海藻酸盐凝胶复合体系应运而生。该体系不仅继承了单一海藻酸盐凝胶的诸多优点，还通过复合显著提高了材料的机械性能，有效克服了应用的局限性。这些复合材料已以多种形式应用于药物输送载体、肿瘤靶向系统和三维肿瘤细胞模型等领域，展现出广泛的应用前景。本文旨在综述海藻酸凝胶的基本结构和性能，分析近年来海藻酸凝胶复合体系在肿瘤领域的研究进展，为进一步拓展该材料在肿瘤治疗中的应用提供有价值的参考。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">关键词<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">水凝胶；海藻酸盐；肿瘤治疗；应用<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:07:26 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4xhr10tdjhfk357bbvn8bha5xv</guid>
    </item>
    <item>
      <title>Exercise therapy: anti-tumor and improving chemotherapy efficacy</title>
      <link>https://jhip.gdpu.edu.cn/4eakdp1shabt174ye1z4ew0jw5</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">Exercise therapy: anti-tumor and
improving chemotherapy efficacy</span><span style="font-size:14.0pt;font-family:
华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:0pt">（</span><span style="font-size:14.0pt;font-family:华文中宋">运动疗法：抗肿瘤和提高化疗疗效</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">）</span><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋"><o:p></o:p></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">研究表明合理的运动对预防和治疗癌症有诸多益处。本文对运动肿瘤学领域进行了文献综述，旨在总结分析运动训练如何对癌症产生影响和运动影响癌症发展的方式，同时为运动肿瘤学基础与临床研究提供重要见解。首先，本文总结了运动与肿瘤进展各方面的关系，包括肿瘤大小、重量、转移、肿瘤血管、肌因子的产生、免疫反应以及癌症化疗的效果等；其次，由于肿瘤性质的多样性，我们还探讨了运动处方的特异性应根据不同的肿瘤类型和患者情况而定，在确定运动的类型、强度、干预和持续时间时，必须考虑个体差异。最后，本文探讨了在未来的临床前研究中，评估运动与传统或新型免疫疗法和药效学之间的相互作用至关重要。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">关键词<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">运动肿瘤学；肿瘤；血管生成；肌因子；微环境；免疫；癌症化疗<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:06:06 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/4eakdp1shabt174ye1z4ew0jw5</guid>
    </item>
    <item>
      <title>The research advance on the theory of Chinese medicine-exterior-interior correlation between the lung and large intestine"</title>
      <link>https://jhip.gdpu.edu.cn/41n3y5hfxtpvj4wg75t39xt4mz</link>
      <description><![CDATA[<p class="MsoNormal"><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">The research advance on the theory of Chinese medicine-exterior-interior
correlation between the lung and large intestine"</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">（中医“肺与大肠相表里”理论指导慢性咳嗽治疗的研究进展）<span lang="EN-US"><o:p></o:p></span></span></p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">摘要<span lang="EN-US">] </span></span></b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;
mso-font-kerning:0pt">&nbsp;</span><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">慢性咳嗽是以咳嗽为唯一或主要症状的慢性呼吸系统疾病，其对现代医学与传统中医学构成了重大挑战。中医理论认为<span lang="EN-US">,</span>“肺与大肠相表里”<span lang="EN-US">,</span>肺与大肠在生理病理上是相互影响的，在治疗咳嗽时肺肠同治、通利肠道，可取得良好的疗效。现代研究也表明，肺与大肠可通过神经通路、黏膜免疫系统、气体交换、微生物菌群等多种途径相互联系。本文从“肺与大肠相表里”角度，依据中西医理论知识与实验研究，阐述了中医药肺肠同治用于慢性咳嗽治疗的相关机制与临床应用，为疾病的治疗提供了有益借鉴。<span lang="EN-US"><o:p></o:p></span></span></p><p>



</p><p class="MsoNormal"><b><span lang="EN-US" style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:仿宋;mso-font-kerning:
0pt">[</span></b><b><span style="font-size:14.0pt;font-family:华文中宋;mso-bidi-font-family:
仿宋;mso-font-kerning:0pt">关键词<span lang="EN-US">]&nbsp;
</span></span></b><span style="font-size:14.0pt;font-family:华文中宋;
mso-bidi-font-family:仿宋;mso-font-kerning:0pt">肺肠轴；慢性咳嗽；中医治疗<span lang="EN-US"><o:p></o:p></span></span></p>]]></description>
      <pubDate>Thu, 10 Oct 2024 08:05:04 GMT</pubDate>
      <guid isPermaLink="true">https://jhip.gdpu.edu.cn/41n3y5hfxtpvj4wg75t39xt4mz</guid>
    </item>
  </channel>
</rss>